Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma

To detect the expression of sphingosine kinase 1 (SPHK1) in clear cell renal cell carcinoma (ccRCC) and explore its biological role in the occurrence and development of ccRCC through regulation of fatty acid metabolism. Using the Cancer Genome Atlas database, SPHK1 expression and its clinical signif...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology, research and practice research and practice, 2023-08, Vol.248, p.154641-154641, Article 154641
Hauptverfasser: Zhao, Leizuo, Wang, Zicheng, Xu, Yingkun, Zhang, Peizhi, Qiu, Jiechuan, Nie, Dengke, Wu, Guangzhen, Chen, Chen, Chang, Yao, Xia, Qinghua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 154641
container_issue
container_start_page 154641
container_title Pathology, research and practice
container_volume 248
creator Zhao, Leizuo
Wang, Zicheng
Xu, Yingkun
Zhang, Peizhi
Qiu, Jiechuan
Nie, Dengke
Wu, Guangzhen
Chen, Chen
Chang, Yao
Xia, Qinghua
description To detect the expression of sphingosine kinase 1 (SPHK1) in clear cell renal cell carcinoma (ccRCC) and explore its biological role in the occurrence and development of ccRCC through regulation of fatty acid metabolism. Using the Cancer Genome Atlas database, SPHK1 expression and its clinical significance were detected in clear cell renal cell carcinoma. Immunohistochemistry was performed to detect SPHK1 expression in RCC samples in our hospital. The connection between the SPHK1 levels and clinicopathological features of patients was assessed. Nile Red was used to detect fatty acids in cells. Cell Counting Kit-8 and 5-ethynyl-2′-deoxyuridine assays were performed to determine the effect of SPHK1 on renal cell viability and proliferation, respectively. Additionally, the effects of SPHK1 on the proliferation and metastasis of ccRCC were studied using wound healing and Transwell assays. Fatty acids were added exogenously in recovery experiments and western blotting was performed to determine the effect of SPHK1 on fatty acid metabolism in ccRCC. Finally, the effects of SPHK1 on tumor growth were investigated in a xenograft model. Bioinformatics analysis revealed that SPHK1 expression was upregulated in kidney RCC. OverSPHK1 expression was associated with poor prognosis for ccRCC patients. High SPHK1 expression was detected in human ccRCC. SPHK1 expression was related to clinicopathological features, such as tumor size and Furman grade. Additionally, cell proliferation, migration, and invasion were inhibited in ccRCC cells with low SPHK1 expression. In rescue experiments, proliferation, migration, and invasion were restored. In vivo, reduced SPHK1 levels correlated with lower expression of fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl CoA carboxylase, and slowed tumor growth. SPHK1 is abnormally overexpressed in human ccRCC. Patients with ccRCC may benefit from treatments that target SPHK1, which may also serve as a prognostic indicator.
doi_str_mv 10.1016/j.prp.2023.154641
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2840248922</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0344033823003412</els_id><sourcerecordid>2840248922</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-64254b6210d2044e5967bb8336b9b1be0b7c38027fcd70a4ee46e72ca9453ccd3</originalsourceid><addsrcrecordid>eNp9kEFPGzEQha2qVUlpf0AvyMdeNoztiXcjTggBRULqoXC2bO8kddi1F3tTiX-Po0CPPc1o9N7Tm4-x7wKWAoQ-3y2nPC0lSLUUK9QoPrCF0KJrQCvxkS1AITagVHfCvpSyA4AWUHxmJ6pF3WqFC_b0e_oT4jaVEIk_hWgLccEzbfeDnanwIUyh5yPN1qUhlJHPiU85jWmmw9xmKiWkyNOmuvtIL9Ub7cD9QDZzT0NdbfYhptF-ZZ82dij07W2esseb64ern839r9u7q8v7xivs5kajXKHTUkAvAZFWa9061yml3doJR-BarzqQ7cb3LVgkQk2t9HaNK-V9r07Zj2NuLfi8pzKbMZRDFRsp7YuRHYLEbi1llYqj1OdUSqaNmXIYbX4xAsyBsdnVy2QOjM2RcfWcvcXv3Uj9P8c71Cq4OAqoPvk3UDbFB4qe-pDJz6ZP4T_xr-d3jaE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2840248922</pqid></control><display><type>article</type><title>Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Zhao, Leizuo ; Wang, Zicheng ; Xu, Yingkun ; Zhang, Peizhi ; Qiu, Jiechuan ; Nie, Dengke ; Wu, Guangzhen ; Chen, Chen ; Chang, Yao ; Xia, Qinghua</creator><creatorcontrib>Zhao, Leizuo ; Wang, Zicheng ; Xu, Yingkun ; Zhang, Peizhi ; Qiu, Jiechuan ; Nie, Dengke ; Wu, Guangzhen ; Chen, Chen ; Chang, Yao ; Xia, Qinghua</creatorcontrib><description>To detect the expression of sphingosine kinase 1 (SPHK1) in clear cell renal cell carcinoma (ccRCC) and explore its biological role in the occurrence and development of ccRCC through regulation of fatty acid metabolism. Using the Cancer Genome Atlas database, SPHK1 expression and its clinical significance were detected in clear cell renal cell carcinoma. Immunohistochemistry was performed to detect SPHK1 expression in RCC samples in our hospital. The connection between the SPHK1 levels and clinicopathological features of patients was assessed. Nile Red was used to detect fatty acids in cells. Cell Counting Kit-8 and 5-ethynyl-2′-deoxyuridine assays were performed to determine the effect of SPHK1 on renal cell viability and proliferation, respectively. Additionally, the effects of SPHK1 on the proliferation and metastasis of ccRCC were studied using wound healing and Transwell assays. Fatty acids were added exogenously in recovery experiments and western blotting was performed to determine the effect of SPHK1 on fatty acid metabolism in ccRCC. Finally, the effects of SPHK1 on tumor growth were investigated in a xenograft model. Bioinformatics analysis revealed that SPHK1 expression was upregulated in kidney RCC. OverSPHK1 expression was associated with poor prognosis for ccRCC patients. High SPHK1 expression was detected in human ccRCC. SPHK1 expression was related to clinicopathological features, such as tumor size and Furman grade. Additionally, cell proliferation, migration, and invasion were inhibited in ccRCC cells with low SPHK1 expression. In rescue experiments, proliferation, migration, and invasion were restored. In vivo, reduced SPHK1 levels correlated with lower expression of fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl CoA carboxylase, and slowed tumor growth. SPHK1 is abnormally overexpressed in human ccRCC. Patients with ccRCC may benefit from treatments that target SPHK1, which may also serve as a prognostic indicator.</description><identifier>ISSN: 0344-0338</identifier><identifier>EISSN: 1618-0631</identifier><identifier>DOI: 10.1016/j.prp.2023.154641</identifier><identifier>PMID: 37467634</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Clear cell renal cell carcinoma ; Fatty acid metabolism ; Progression ; Sphingosine kinase 1 ; The Cancer Genome Atlas</subject><ispartof>Pathology, research and practice, 2023-08, Vol.248, p.154641-154641, Article 154641</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-64254b6210d2044e5967bb8336b9b1be0b7c38027fcd70a4ee46e72ca9453ccd3</cites><orcidid>0000-0002-1331-4207</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0344033823003412$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37467634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Leizuo</creatorcontrib><creatorcontrib>Wang, Zicheng</creatorcontrib><creatorcontrib>Xu, Yingkun</creatorcontrib><creatorcontrib>Zhang, Peizhi</creatorcontrib><creatorcontrib>Qiu, Jiechuan</creatorcontrib><creatorcontrib>Nie, Dengke</creatorcontrib><creatorcontrib>Wu, Guangzhen</creatorcontrib><creatorcontrib>Chen, Chen</creatorcontrib><creatorcontrib>Chang, Yao</creatorcontrib><creatorcontrib>Xia, Qinghua</creatorcontrib><title>Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma</title><title>Pathology, research and practice</title><addtitle>Pathol Res Pract</addtitle><description>To detect the expression of sphingosine kinase 1 (SPHK1) in clear cell renal cell carcinoma (ccRCC) and explore its biological role in the occurrence and development of ccRCC through regulation of fatty acid metabolism. Using the Cancer Genome Atlas database, SPHK1 expression and its clinical significance were detected in clear cell renal cell carcinoma. Immunohistochemistry was performed to detect SPHK1 expression in RCC samples in our hospital. The connection between the SPHK1 levels and clinicopathological features of patients was assessed. Nile Red was used to detect fatty acids in cells. Cell Counting Kit-8 and 5-ethynyl-2′-deoxyuridine assays were performed to determine the effect of SPHK1 on renal cell viability and proliferation, respectively. Additionally, the effects of SPHK1 on the proliferation and metastasis of ccRCC were studied using wound healing and Transwell assays. Fatty acids were added exogenously in recovery experiments and western blotting was performed to determine the effect of SPHK1 on fatty acid metabolism in ccRCC. Finally, the effects of SPHK1 on tumor growth were investigated in a xenograft model. Bioinformatics analysis revealed that SPHK1 expression was upregulated in kidney RCC. OverSPHK1 expression was associated with poor prognosis for ccRCC patients. High SPHK1 expression was detected in human ccRCC. SPHK1 expression was related to clinicopathological features, such as tumor size and Furman grade. Additionally, cell proliferation, migration, and invasion were inhibited in ccRCC cells with low SPHK1 expression. In rescue experiments, proliferation, migration, and invasion were restored. In vivo, reduced SPHK1 levels correlated with lower expression of fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl CoA carboxylase, and slowed tumor growth. SPHK1 is abnormally overexpressed in human ccRCC. Patients with ccRCC may benefit from treatments that target SPHK1, which may also serve as a prognostic indicator.</description><subject>Clear cell renal cell carcinoma</subject><subject>Fatty acid metabolism</subject><subject>Progression</subject><subject>Sphingosine kinase 1</subject><subject>The Cancer Genome Atlas</subject><issn>0344-0338</issn><issn>1618-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kEFPGzEQha2qVUlpf0AvyMdeNoztiXcjTggBRULqoXC2bO8kddi1F3tTiX-Po0CPPc1o9N7Tm4-x7wKWAoQ-3y2nPC0lSLUUK9QoPrCF0KJrQCvxkS1AITagVHfCvpSyA4AWUHxmJ6pF3WqFC_b0e_oT4jaVEIk_hWgLccEzbfeDnanwIUyh5yPN1qUhlJHPiU85jWmmw9xmKiWkyNOmuvtIL9Ub7cD9QDZzT0NdbfYhptF-ZZ82dij07W2esseb64ern839r9u7q8v7xivs5kajXKHTUkAvAZFWa9061yml3doJR-BarzqQ7cb3LVgkQk2t9HaNK-V9r07Zj2NuLfi8pzKbMZRDFRsp7YuRHYLEbi1llYqj1OdUSqaNmXIYbX4xAsyBsdnVy2QOjM2RcfWcvcXv3Uj9P8c71Cq4OAqoPvk3UDbFB4qe-pDJz6ZP4T_xr-d3jaE</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Zhao, Leizuo</creator><creator>Wang, Zicheng</creator><creator>Xu, Yingkun</creator><creator>Zhang, Peizhi</creator><creator>Qiu, Jiechuan</creator><creator>Nie, Dengke</creator><creator>Wu, Guangzhen</creator><creator>Chen, Chen</creator><creator>Chang, Yao</creator><creator>Xia, Qinghua</creator><general>Elsevier GmbH</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1331-4207</orcidid></search><sort><creationdate>20230801</creationdate><title>Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma</title><author>Zhao, Leizuo ; Wang, Zicheng ; Xu, Yingkun ; Zhang, Peizhi ; Qiu, Jiechuan ; Nie, Dengke ; Wu, Guangzhen ; Chen, Chen ; Chang, Yao ; Xia, Qinghua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-64254b6210d2044e5967bb8336b9b1be0b7c38027fcd70a4ee46e72ca9453ccd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Clear cell renal cell carcinoma</topic><topic>Fatty acid metabolism</topic><topic>Progression</topic><topic>Sphingosine kinase 1</topic><topic>The Cancer Genome Atlas</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Leizuo</creatorcontrib><creatorcontrib>Wang, Zicheng</creatorcontrib><creatorcontrib>Xu, Yingkun</creatorcontrib><creatorcontrib>Zhang, Peizhi</creatorcontrib><creatorcontrib>Qiu, Jiechuan</creatorcontrib><creatorcontrib>Nie, Dengke</creatorcontrib><creatorcontrib>Wu, Guangzhen</creatorcontrib><creatorcontrib>Chen, Chen</creatorcontrib><creatorcontrib>Chang, Yao</creatorcontrib><creatorcontrib>Xia, Qinghua</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology, research and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Leizuo</au><au>Wang, Zicheng</au><au>Xu, Yingkun</au><au>Zhang, Peizhi</au><au>Qiu, Jiechuan</au><au>Nie, Dengke</au><au>Wu, Guangzhen</au><au>Chen, Chen</au><au>Chang, Yao</au><au>Xia, Qinghua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma</atitle><jtitle>Pathology, research and practice</jtitle><addtitle>Pathol Res Pract</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>248</volume><spage>154641</spage><epage>154641</epage><pages>154641-154641</pages><artnum>154641</artnum><issn>0344-0338</issn><eissn>1618-0631</eissn><abstract>To detect the expression of sphingosine kinase 1 (SPHK1) in clear cell renal cell carcinoma (ccRCC) and explore its biological role in the occurrence and development of ccRCC through regulation of fatty acid metabolism. Using the Cancer Genome Atlas database, SPHK1 expression and its clinical significance were detected in clear cell renal cell carcinoma. Immunohistochemistry was performed to detect SPHK1 expression in RCC samples in our hospital. The connection between the SPHK1 levels and clinicopathological features of patients was assessed. Nile Red was used to detect fatty acids in cells. Cell Counting Kit-8 and 5-ethynyl-2′-deoxyuridine assays were performed to determine the effect of SPHK1 on renal cell viability and proliferation, respectively. Additionally, the effects of SPHK1 on the proliferation and metastasis of ccRCC were studied using wound healing and Transwell assays. Fatty acids were added exogenously in recovery experiments and western blotting was performed to determine the effect of SPHK1 on fatty acid metabolism in ccRCC. Finally, the effects of SPHK1 on tumor growth were investigated in a xenograft model. Bioinformatics analysis revealed that SPHK1 expression was upregulated in kidney RCC. OverSPHK1 expression was associated with poor prognosis for ccRCC patients. High SPHK1 expression was detected in human ccRCC. SPHK1 expression was related to clinicopathological features, such as tumor size and Furman grade. Additionally, cell proliferation, migration, and invasion were inhibited in ccRCC cells with low SPHK1 expression. In rescue experiments, proliferation, migration, and invasion were restored. In vivo, reduced SPHK1 levels correlated with lower expression of fatty acid synthase, stearoyl-CoA desaturase 1, and acetyl CoA carboxylase, and slowed tumor growth. SPHK1 is abnormally overexpressed in human ccRCC. Patients with ccRCC may benefit from treatments that target SPHK1, which may also serve as a prognostic indicator.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>37467634</pmid><doi>10.1016/j.prp.2023.154641</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-1331-4207</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0344-0338
ispartof Pathology, research and practice, 2023-08, Vol.248, p.154641-154641, Article 154641
issn 0344-0338
1618-0631
language eng
recordid cdi_proquest_miscellaneous_2840248922
source Elsevier ScienceDirect Journals Complete
subjects Clear cell renal cell carcinoma
Fatty acid metabolism
Progression
Sphingosine kinase 1
The Cancer Genome Atlas
title Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A40%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sphingosine%20kinase%201%20regulates%20lipid%20metabolism%20to%20promote%20progression%20of%20kidney%20renal%20clear%20cell%20carcinoma&rft.jtitle=Pathology,%20research%20and%20practice&rft.au=Zhao,%20Leizuo&rft.date=2023-08-01&rft.volume=248&rft.spage=154641&rft.epage=154641&rft.pages=154641-154641&rft.artnum=154641&rft.issn=0344-0338&rft.eissn=1618-0631&rft_id=info:doi/10.1016/j.prp.2023.154641&rft_dat=%3Cproquest_cross%3E2840248922%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2840248922&rft_id=info:pmid/37467634&rft_els_id=S0344033823003412&rfr_iscdi=true